Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four ...

One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks, join 'Squawk on the Street' to discuss the company's U.S. manufacturing sites expansion, tariffs and domestic jobs.

In August 2024, the company opened the research and development hub, Lilly Seaport Innovation Center, in Boston's Seaport district, US. "Eli Lilly to expand US pharma manufacturing with four new ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately ... In total, the Boston-based precision medicine firm can potentially earn more ...

Eli Lilly's GLP-1 drugs Mounjaro and Zepbound are ... the company opened the $700 million Lilly Institute for Genetic Medicine in Boston, away from Lilly's headquarters in Indianapolis and in ...

Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is making larger doses available for $499 through its self-pay program.

Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & CompanyTwo lead programs in ...